One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...

And it’s a problem with humankind in general. We do tend to crave quick fixes, often in pharmaceutical form. That’s why Henry Dimbleby, a food campaigner and founder of Leon, called Ozempic “the ...

In accordance with the fmcg rule above, the petcare category is similarly awash with tummy-centric products. Just this month, ...

As lawyers who represent whistleblowers under the False Claims Act, we expect a new era of fraud cases tied to GLP-1 drugs, ...

With anti-obesity drugs like semaglutide set to drop in price from a staggering Rs 30,000 to just Rs 3,000 per month, ...

FAT jabs could be made available over the ­counter at pharmacies without the need for a GP to get involved. It is one idea ...

Peter Kyle said he wants the likes of Wegovy and Mounjaro to be 'widely used' and made 'available to everyone from every ...

Weight loss drugs can’t replace the power of group support for lasting weight loss, says a Morecambe Slimming World consultant.

New studies confirm a small increased risk of serious eye conditions and vision loss in people taking weight-loss drugs like Ozempic, Wegovy, and Mounjaro.